Metraipolis › archive › dc_b6846659efbc

Pharmacogenomics of Tirzepatide: Genomic Insights into Dual GIP/GLP-1 Agonist Response in Type 2 Diabetes and Atherosclerosis — Europe PMC PMID:41011133

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41011133
DOI
10.3390/ph18091261
License (as archived)
solo-consultazione
Archived
2026-11-10T09:38:39.802Z
SHA-256 of the archived text
1c79264a0af13eacd91201dab67ce17406134ff6be8c089748e8c7bc635d1efe
Stable URL of this page
https://metraipolis.com/documento/dc_b6846659efbc

How to cite

Pharmacogenomics of Tirzepatide: Genomic Insights into Dual GIP/GLP-1 Agonist Response in Type 2 Diabetes and Atherosclerosis — Europe PMC PMID:41011133 — Europe PMC (en), https://europepmc.org/article/MED/41011133 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b6846659efbc (Metraipolis archive dc_b6846659efbc, sha256 1c79264a0af13eacd91201dab67ce17406134ff6be8c089748e8c7bc635d1efe)
BibTeX
@misc{dcb6846659efbc,
  title = {Pharmacogenomics of Tirzepatide: Genomic Insights into Dual GIP/GLP-1 Agonist Response in Type 2 Diabetes and Atherosclerosis — Europe PMC PMID:41011133},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41011133},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b6846659efbc; sha256 1c79264a0af13eacd91201dab67ce17406134ff6be8c089748e8c7bc635d1efe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41011133. Agents can read the archived copy with the MCP tool read_document.